These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18832243)

  • 41. Statin therapy: not just used to lower cholesterol?
    Kronmann L; Hatfield C; Kronmann K
    Crit Care Nurs Q; 2007; 30(2):154-60. PubMed ID: 17356356
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hydroxymethylglutaryl coenzyme A reductase inhibitors].
    Schuff-Werner P
    Internist (Berl); 1994 Mar; 35(3):288-94; discussion 295. PubMed ID: 8175295
    [No Abstract]   [Full Text] [Related]  

  • 43. Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction.
    Ito MK; Talbert RL; Tsimikas S
    Pharmacotherapy; 2006 Jul; 26(7 Pt 2):85S-97S; discussion 98S-101S; quiz 106S-108S. PubMed ID: 16803418
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Transplant coronary artery disease--treatment with statins].
    Wolszakiewicz J; Bilińska M
    Pol Merkur Lekarski; 2004 May; 16(95):472-3. PubMed ID: 15518430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Eligibility for lipid-lowering drug therapy in primary prevention: how do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines compare?
    Gotto AM; Kuller LH
    Circulation; 2002 Jan; 105(2):136-9. PubMed ID: 11790688
    [No Abstract]   [Full Text] [Related]  

  • 46. Statins in the era of evidence-based medicine--who will not "prosper"?
    McDougall C; Perry CG; Sattar N; Petrie JR
    Scott Med J; 2003 Aug; 48(3):64-8. PubMed ID: 12968509
    [No Abstract]   [Full Text] [Related]  

  • 47. [HMG-CoA reductase inhibitors in therapy of disorders of lipid metabolism].
    Windler E; Greten H
    Internist (Berl); 1993 Dec; 34(12):1107-14. PubMed ID: 8106206
    [No Abstract]   [Full Text] [Related]  

  • 48. [The impact HMG-CoA reductase inhibitors on the modification of the natural history of coronary artery disease].
    Kaiser SE; de Alcantara ML
    Arq Bras Cardiol; 1998 Aug; 71(2):153-62. PubMed ID: 9816690
    [No Abstract]   [Full Text] [Related]  

  • 49. Stopping statins is bad for your health.
    Sherman FT
    Geriatrics; 2004 Nov; 59(11):8, 10. PubMed ID: 15615155
    [No Abstract]   [Full Text] [Related]  

  • 50. Stents, statins, and other dumb luck.
    Robbins P
    J Biol Chem; 2011 Jan; 286(3):1669-74. PubMed ID: 21098482
    [No Abstract]   [Full Text] [Related]  

  • 51. Statins for primary prevention of coronary artery disease.
    McPherson R; Kavaslar N
    Lancet; 2007 Mar; 369(9567):1078; author reply 1079. PubMed ID: 17398299
    [No Abstract]   [Full Text] [Related]  

  • 52. Secondary prevention of heart disease with statins: findings are unexpected.
    Fleetcroft R; Steel N
    BMJ; 2005 May; 330(7501):1208; author reply 1208-9. PubMed ID: 15905262
    [No Abstract]   [Full Text] [Related]  

  • 53. Statins and cancer--beyond the "one drug, one disease" model.
    Hawk E; Viner JL
    N Engl J Med; 2005 May; 352(21):2238-9. PubMed ID: 15917390
    [No Abstract]   [Full Text] [Related]  

  • 54. Secondary prevention of heart disease with statins: study seems to be about tertiary rather than secondary prevention.
    Mills CJ
    BMJ; 2005 May; 330(7501):1208; author reply 1208-9. PubMed ID: 15905261
    [No Abstract]   [Full Text] [Related]  

  • 55. Anti-lipid trial endpoints.
    Orloff DG
    Am J Ther; 1999 Mar; 6(2):115-9. PubMed ID: 10610245
    [No Abstract]   [Full Text] [Related]  

  • 56. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. 1995.
    Shepherd J; Cobbe SM; Ford I; Isles CG; Lorimer AR; MacFarlane PW; McKillop JH; Packard CJ;
    Atheroscler Suppl; 2004 Oct; 5(3):91-7. PubMed ID: 15531281
    [No Abstract]   [Full Text] [Related]  

  • 57. Statins: to use or not to use with elevated LFTs?
    Gillies TJ
    S D Med; 2011 Apr; 64(4):133-4. PubMed ID: 21560996
    [No Abstract]   [Full Text] [Related]  

  • 58. Primary prevention and statins: is it just about going to class?
    Krasuski RA
    Mayo Clin Proc; 2008 Dec; 83(12):1313-5. PubMed ID: 19046549
    [No Abstract]   [Full Text] [Related]  

  • 59. Hormone therapy and risk of all-cause mortality in women treated with statins.
    Hodis HN; Mack WJ
    Menopause; 2015 Apr; 22(4):363-4. PubMed ID: 25756694
    [No Abstract]   [Full Text] [Related]  

  • 60. Statins for primary prevention: strategic options to save lives and money.
    Shepherd J
    J R Soc Med; 2004 Feb; 97(2):66-71. PubMed ID: 14749400
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.